Navigation Links
Boston Scientific Announces First Implants of TELIGEN® Implantable Defibrillator in China
Date:2/23/2012

NATICK, Mass., Feb. 23, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces the first implants of a TELIGEN® implantable cardioverter defibrillator (ICD) in China.  The implants were performed by Farong Shen, M.D., in Zhejiang Hospital, Hangzhou and Wei Hua, M.D., in Fuwai Hospital, Beijing.  The TELIGEN family of ICDs, designed to treat sudden cardiac death, are the smallest and thinnest high-energy devices available in China.  The devices offer extended battery longevity over previous Boston Scientific ICDs currently approved in China, as well as improved programming technology to offer patients enhanced clinical options.  The TELIGEN family of devices was approved by the State Food and Drug Administration (SFDA) of the People's Republic of China in November 2011.Shu Zhang, M.D., Chairman of the Chinese Society of Pacing and Electrophysiology, stated, "These new ICDs feature significant advances and will be a welcome technology for Chinese patients requiring implantable defibrillators."  Wei Hua, M.D., added, "The TELIGEN devices provide patients the thinnest ICDs with the longest projected longevity available, without compromising therapy options."  Farong Shen, M.D., also added, "In the past, I often had to sacrifice longevity, device size, or features when selecting an ICD for my patients.  The TELIGEN device delivers a complete solution."

"Boston Scientific is committed to providing innovative products and therapies to Chinese physicians and their patients," said Joe Fitzgerald, Senior Vice President and President of the Cardiac Rhythm Management group at Boston Scientific.  "We believe today's first implant of our advanced ICDs combined with our recent launch of the PROMUS Element™ Plus Coronary Stent System in China positions Boston Scientific for future growth in this important market."

<
'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Boston Scientific Receives Industrys First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients
2. Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries
3. Boston Scientific to Participate in Leerink Swann 2012 Global Healthcare Conference
4. Boston Scientific Announces First Implant and Market Launch of PROMUS Element™ Plus Stent System in Europe
5. Boston IVF Pioneers Worlds First Needle-Free Saliva Test Used in Infertility Treatment; Patient Friendly Monitoring Replaces Daily Blood Tests
6. Boston Scientific Announces Favorable Ruling in Patent Infringement Case
7. Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial
8. nContacts Cardiac Ablation Technology to be Presented in Two Noteworthy Posters at Boston Atrial Fibrillation Symposium 2012
9. Boston Scientific Raises Awareness of Heart Disease at Brandon Jennings Invitational
10. Boston Scientifics Alair® Bronchial Thermoplasty System Achieves Important Reimbursement Milestones
11. Boston Scientific to Participate in 30th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 Research and Markets ... Market by Equipment, by Reagent, by Application - Global ... http://photos.prnewswire.com/prnh/20130307/600769 Biopharmaceuticals ... is one of the most important and widely used ... application segment of the cell culture market in 2013. ...
(Date:7/22/2014)... Mass. , July 22, 2014  Decision ... audited multiple sclerosis (MS) patients currently treated ... Tecfidera have ever experienced flushing and/or gastrointestinal ... Tecfidera-treated patients are currently experiencing these side ... the effective medical management of such events. ...
(Date:7/22/2014)... 2014 The number of people overdosing from ... day. Twenty-three percent of the workforce has misused prescription ... and Health, making opioid use a serious threat to ... at the correct dosage with a valid prescription, subtle ... National Safety Council released a guide for ...
Breaking Medicine Technology:Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 2Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 35 things employers should know about prescription painkiller use 25 things employers should know about prescription painkiller use 3
... Hospital today announced that revolutionary three-dimensional mammography imaging ... patient appointments at the Evergreen Breast Center, which ... Seattle area to offer the breakthrough screening and ... three-dimensional (3-D) digital imaging to create a complete ...
... Prescription drug spending growth slowed from an estimated ... according to new data released today by the Centers ... in Health Affairs. Researchers credit the slowdown in spending ... shifting medication use toward lower cost generic drugs. ...
Cached Medicine Technology:Evergreen Hospital Launches Revolutionary Breast Cancer Detection and Diagnostic Imaging Technology 2Evergreen Hospital Launches Revolutionary Breast Cancer Detection and Diagnostic Imaging Technology 3PCMA: Study Credits PBM Tools with Reducing Prescription Drug Spending Growth 2
(Date:7/22/2014)... American Society of Hematology (ASH) will honor Michael DeBaun, ... Robert P. Hebbel, MD, of the University of Minnesota ... Prize for their significant research advances in the area ... named for the late Ernest Beutler, MD, a past ... years, is a two-part lectureship that recognizes major translational ...
(Date:7/22/2014)... director of research at the University of Utah,s John ... International Society of Eye Research (ISER) as the recipient ... Kayser International Award in Retina Research., The award recognizes ... a significant contribution to the understanding of vitreoretinal diseases ... at the ISER Biennial Meeting in San Francisco, where ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Legislation ... Seniors Access to Local Pharmacies Act of 2014”) ... Part D would undermine the availability of lower ... by $21 billion over the next 10 years, ... released by the Pharmaceutical Care Management Association (PCMA). ...
(Date:7/22/2014)... WASHINGTON -- Autoimmune disorders may share certain pathogenic mechanisms ... Washington University (GW) researcher Linda Kusner, Ph.D. , ... , This paradigm shifting work shows that the very ... are also expressed in cells that produce autoimmune diseases. ... of Neurology at the GW School of Medicine and ...
(Date:7/22/2014)... The Beryl Institute announces its fifth annual Patient ... These offerings reinforce the Institute’s commitment to support the ... the need for rigorous research to understand and address ... are intended to encourage and support research into ... the patient experience before, during and after care (e.g., ...
Breaking Medicine News(10 mins):Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 2Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 4Health News:University of Utah researcher Robert Marc receives Paul Kayser International Award 2Health News:PCMA: New Study Finds H.R. 4577 to Cost $21 Billion Over 10 Years 2Health News:New research finds pathogenic connection between autoimmune disorders and cancer 2Health News:The Beryl Institute Opens Applications for 2014 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2014 Patient Experience Grant and Scholar Programs 3
... fluid in the middle ear, a condition called otitis media ... by antihistamines and decongestants, a new review of studies has ... in alleviating symptoms or avoiding complications of OME and expose ... ,"This review finds no benefit for any of the ...
... Virginia University professor and two alumni have tracked the ... the eye and often leads to blindness and death.// ... treatment for those who suffer from it. ,Joginder ... doctoral students Jason White ('02) and Alison Director-Myska ('96) ...
... Federal government of Australia came under the glaring critics ... its allocation of funds for various health promotion programs.// ... at the current government for lapses pertaining to health ... from rural medical facilities pharmaceuticals and after hour care ...
... the gut has been found to be an effective ... researchers at Cedars-Sinai Medical Center. ,The study ... the Annals of Internal Medicine It is the ... end of the course of treatment has ended. This ...
... reports that the board of the Central Gippsland Health Service ... ,Peter Goss and Jo McCubbin had resigned from the Sale ... such an action because of threats to services. However they ... place. ,In an open letter to the hospital board, ...
... Cancer’s exploits are titillated by personality traits, contemplates a ... rodents//. The idea that personality types may increase the ... ,Researchers at the University of Chicago ... point for cancer as compared to the rats that ...
Cached Medicine News:Health News:Allergy Drugs More Harmful Than Helpful for Chronic Ear Inflammation 2Health News:Allergy Drugs More Harmful Than Helpful for Chronic Ear Inflammation 3Health News:Team Tracks Genetic Origins of Eye Cancer 2Health News:Federal government blamed for allocating meager portion to health sector:ALP 2Health News:IBS Sufferers Benefited by Non-Absorbable Antibiotics 2
... The BacT/Alert 3D Signature is ... microbial detection system that integrates blood, ... It is a powerful microbiology workstation ... for higher volume identification and where ...
... Vitek is a completely automated instrument that ... 2 - 6 hour same day turnaround), ... control module. It is used for bacterial ... urine screening and has a complete data ...
IDS Rapid One, a microbial identification system....
The Cogent Microbial Luminescence System (MLS) is a superior Rapid microbial detection system for UHT product screening combining proven technology of ATP-bioluminescence with unsurpassed hardware in...
Medicine Products: